SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-096193
Filing Date
2022-04-05
Accepted
2022-04-05 16:21:02
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d312403ddefa14a.htm DEFA14A 14320
2 GRAPHIC g312403g01m01.jpg GRAPHIC 408728
3 GRAPHIC g312403g02m02.jpg GRAPHIC 279056
  Complete submission text file 0001193125-22-096193.txt   962985
Mailing Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36407 | Film No.: 22807152
SIC: 2834 Pharmaceutical Preparations